Literature DB >> 184771

Human conjunctivitis. II. Treatment.

H M Leibowitz, M V Pratt, I J Flagstad, A R Berrospi, R Kundsin.   

Abstract

One hundred forty-three patients (207 eyes) with conjunctivitis or blepharoconjunctivitis were investigated to determine (1) the safety of topical corticosteroid therapy and the relative efficacy of formulations of increasing potency and (2) the effectiveness of a steroid-antibiotic preparation compared to each of its components alone and to a placebo. The corticosteroids were equally effective in suppressing conjunctival inflammation; all were more effective than the placebo. Active conjunctivitis was controlled more readily by those preparations containing a steroid, both alone and in combination. The corticosteroid alone (dexamethasone) was more effective in producing inactivation of conjunctivitis than the antibiotic alone ( a mixture of neomycin sulfate and polymyxin B sulfate). This observation remained unchanged when cases of Staphylococcus aureus conjunctivitis were analyzed separately. No serious complications resulted from any treatment regimen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184771     DOI: 10.1001/archopht.1976.03910040526011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

Authors:  A Sheikh; B Hurwitz
Journal:  Br J Gen Pract       Date:  2001-06       Impact factor: 5.386

2.  Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

Authors:  J A Jacobson; N B Call; E M Kasworm; M S Dirks; R B Turner
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study.

Authors:  Ricardo Notivol; Dina Amin; Anna Whitling; David Wells; Margaret Kennedy; Paul C Cockrum
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

4.  Netilmicin/dexamethasone fixed combination in the treatment of conjunctival inflammation.

Authors:  Francesco Faraldi; Vincenzo Papa; Daria Rasà; Debora Santoro; Simona Russo
Journal:  Clin Ophthalmol       Date:  2013-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.